Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 4
2011 3
2012 2
2013 2
2014 2
2015 9
2016 11
2017 10
2018 20
2019 10
2020 13
2021 18
2022 17
2023 14
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Comment on Umapathysivam et al. Euglycemic Ketoacidosis in Two Patients Without Diabetes After Introduction of Sodium-Glucose Cotransporter 2 Inhibitor for Heart Failure With Reduced Ejection Fraction. Diabetes Care 2024;47:140-143.
Ninon F, Alice L, Marie-Amélie BM, Laurence B, Kamel M, Thierry C, Sami F, Yann P, Vincent R. Ninon F, et al. Among authors: kamel m. Diabetes Care. 2024 Apr 1;47(4):e35. doi: 10.2337/dc24-0094. Diabetes Care. 2024. PMID: 38527115 No abstract available.
Impact of exenatide on weight loss and eating behavior in adults with craniopharyngioma-related obesity: the CRANIOEXE randomized placebo-controlled trial.
Gatta-Cherifi B, Mohammedi K, Cariou T, Poitou C, Touraine P, Raverot G, Brue T, Chanson P, Illouz F, Grunenwald S, Chabre O, Sonnet E, Cuny T, Bertherat J, Czernichow S, Frison E, Tabarin A. Gatta-Cherifi B, et al. Among authors: mohammedi k. Eur J Endocrinol. 2024 Mar 30;190(4):257-265. doi: 10.1093/ejendo/lvae024. Eur J Endocrinol. 2024. PMID: 38450721 Clinical Trial.
Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study.
Alkhami F, Borderie G, Foussard N, Larroumet A, Blanco L, Barbet-Massin MA, Ferriere A, Ducos C, Mohammedi K, Fawaz S, Couffinhal T, Rigalleau V. Alkhami F, et al. Among authors: mohammedi k. Diabetes Metab. 2024 Mar;50(2):101524. doi: 10.1016/j.diabet.2024.101524. Epub 2024 Feb 11. Diabetes Metab. 2024. PMID: 38346471
The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures.
Alkhami F, Borderie G, Foussard N, Larroumet A, Blanco L, Barbet-Massin MA, Ferriere A, Ducos C, Mohammedi K, Fawaz S, Couffinhal T, Rigalleau V. Alkhami F, et al. Among authors: mohammedi k. Cardiovasc Diabetol. 2024 Jan 13;23(1):32. doi: 10.1186/s12933-024-02121-5. Cardiovasc Diabetol. 2024. PMID: 38218857 Free PMC article.
Comment on Peker, T.; Boyraz, B. The Relationship between Resistant Hypertension and Advanced Glycation End-Product Levels Measured Using the Skin Autofluorescence Method: A Case-Control Study. J. Clin. Med. 2023, 12, 6606.
Alkhami F, Foussard N, Larroumet A, Barbet-Massin MA, Blanco L, Mohammedi K, Rigalleau V. Alkhami F, et al. Among authors: mohammedi k. J Clin Med. 2023 Dec 8;12(24):7562. doi: 10.3390/jcm12247562. J Clin Med. 2023. PMID: 38137634 Free PMC article.
Cost-effectiveness of screening of coronary artery disease in patients with type 2 diabetes at a very high cardiovascular risk (SCADIAB) study. Updated study design: emulation of a randomised target trial using electronic health records.
Mohammedi K, Cordon A, Rigalleau V, Foussard N, Bairras-Martin C, Couffinhal T, Bezin J, Benard A. Mohammedi K, et al. Cardiovasc Diabetol. 2023 Nov 28;22(1):329. doi: 10.1186/s12933-023-02069-y. Cardiovasc Diabetol. 2023. PMID: 38017442 Free PMC article. No abstract available.
131 results